C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
120+ members of multi-disciplinary medical team are trained to provide seamless, outcome driven trauma and emergency care
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
The product will be launched by NATCO's commercial partner Viatris.
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Subscribe To Our Newsletter & Stay Updated